Welcure Drugs & Pharmaceuticals Ltd

Welcure Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Welcure Drugs & Pharmaceuticals Ltd

₹ 0.61 -4.69%
14 Nov - close price
Company website BSE: 524661
About

Incorporated in 1992, Welcure Drugs and Pharmaceuticals Ltd is in the business of pharmaceutical and healthcare.[1]

Key Points

Business Overview:[1]
WDPL is engaged in the manufacture and
trade of a wide range of healthcare formulations.

Website BSE
  • Market Cap ₹ 75.4 Cr.
  • Current Price ₹ 0.61
  • High / Low ₹ 1.45 / 0.48
  • Stock P/E 2.19
  • Book Value ₹ 1.09
  • Dividend Yield 0.00 %
  • ROCE 2.53 %
  • ROE 4.18 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Stock is trading at 0.56 times its book value
  • Company has delivered good profit growth of 194% CAGR over last 5 years

Cons

  • Company has a low return on equity of 3.84% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 282 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 24.55 0.88 21.21 299.91 65.62
0.02 0.01 0.05 0.03 0.09 0.06 0.06 0.34 22.71 0.79 20.57 268.77 54.25
Operating Profit -0.02 -0.01 -0.05 -0.03 -0.09 -0.06 -0.06 -0.34 1.84 0.09 0.64 31.14 11.37
OPM % 7.49% 10.23% 3.02% 10.38% 17.33%
0.01 0.01 0.22 0.00 0.00 0.04 0.06 0.00 0.00 0.00 1.91 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.01 0.01 0.02 0.00 0.01 0.00 0.01 0.00 0.00
Profit before tax -0.01 0.00 0.17 -0.03 -0.10 -0.03 -0.02 -0.34 1.83 0.09 2.54 31.14 11.37
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 55.56% 0.00% 25.18% 25.15%
-0.01 0.00 0.17 -0.03 -0.10 -0.03 -0.02 -0.34 1.84 0.04 2.54 23.30 8.50
EPS in Rs -0.00 0.00 0.01 -0.00 -0.01 -0.00 -0.00 -0.02 0.01 0.00 0.02 0.19 0.07
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
0 0 0 0 0 0 0 0 0 0 0 25 388
0 0 0 0 0 0 0 0 0 0 0 24 344
Operating Profit -0 0 0 0 -0 0 -0 0 0 -0 -0 1 43
OPM % -25% 20% 40% 33% -40% 0% -12% 46% 18% 4% 11%
0 0 0 0 0 0 0 0 0 0 0 2 2
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 0 0 0 0 -0 0 -0 0 0 0 -0 3 45
Tax % 0% 0% 0% 0% 0% 0% 0% 0% 0% 22%
0 0 0 0 -0 0 -0 0 0 0 -0 2 34
EPS in Rs 0.00 0.00 0.01 0.00 -0.00 0.00 -0.00 0.00 0.00 0.01 -0.01 0.02 0.28
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 86%
5 Years: 214%
3 Years: 507%
TTM: 1479%
Compounded Profit Growth
10 Years: 71%
5 Years: 194%
3 Years: 377%
TTM: 2271%
Stock Price CAGR
10 Years: 12%
5 Years: 28%
3 Years: -4%
1 Year: -16%
Return on Equity
10 Years: %
5 Years: 4%
3 Years: 4%
Last Year: 4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 12 12 12 12 12 12 12 12 12 13 13 112 112
Reserves -12 -12 -12 -12 -12 -12 -12 -12 -12 -12 -12 -10 22
0 0 0 0 0 0 0 0 0 0 0 123 123
0 0 0 0 0 0 0 0 0 0 0 41 375
Total Liabilities 0 0 0 0 0 0 0 0 0 2 1 267 633
0 0 0 0 0 0 0 0 0 0 0 0 0
CWIP 0 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 1 1 267 633
Total Assets 0 0 0 0 0 0 0 0 0 2 1 267 633

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 0 -0 0 -0 0 -0 0 0 0 -0 -222
-0 0 0 0 0 0 0 0 0 0 0 -0
0 0 0 0 0 0 0 0 0 -0 -0 222
Net Cash Flow -0 0 -0 0 -0 0 -0 0 0 -0 0 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 0 0 0 0 0 0 0 0 0 282
Inventory Days 2,554
Days Payable 52
Cash Conversion Cycle 0 0 0 0 0 0 0 0 0 2,784
Working Capital Days -1,186 -876 36 81 73 46 0 0 0 2,092
ROCE % 120% -67% 0% -40% 133% 25% 10% -13% 3%

Shareholding Pattern

Numbers in percentages

129 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
0.01% 0.01% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
99.99% 99.99% 100.00% 100.00% 99.99% 100.00% 100.00% 100.00% 100.00% 99.98% 99.99% 99.99%
No. of Shareholders 29,07529,01329,25129,59329,95731,53031,04530,21830,60532,36637,29876,954

Documents

Announcements

Annual reports